Showing 85 of 85on this page. Filters & sort apply to loaded results; URL updates for sharing.85 of 85 on this page
LimmaTech Biologics: $3 Million Secured To Combat The Global ...
LimmaTech Biologics - Crunchbase Investor Profile & Investments
Working at LimmaTech biologics | Glassdoor
LimmaTech Biologics - 2025 Funding Rounds & List of Investors - Tracxn
LimmaTech Biologics AG on LinkedIn: #vaccines #antimicrobialresistance ...
LimmaTech Bio cooperating with GSK on vaccine development | S-GE
LimmaTech Biologics | Most Promising BioTech Startup in Europe-2020
#vaccinedevelopment #globalhealth #antimicrobialresistance | LimmaTech ...
LimmaTech secures funding for vaccine technology development
LimmaTech Biologics AG – swissclick ag
LimmaTech offers prophylactic vaccines for gonorrhea | LimmaTech ...
Neues Projekt: LimmaTech Biologics – swissclick ag
LimmaTech Biologics Raises USD 37m Series A to Advance Its Pipeline of ...
LimmaTech Biologics AG – Swiss Biotech
LimmaTech Biologics AG - startup.ch
Proprietary Vaccine Platform | LimmaTech Biologics AG
Investors | LimmaTech Biologics AG
Company | LimmaTech Biologics AG
GSK Grants LimmaTech Biologics License to Develop and Commercialize ...
Valneva and LimmaTech partner for shigellosis vaccine development ...
LimmaTech impft erstmals in Phase-1-Studie mit LBT-SA7 – Life Science ...
LimmaTech secures US$6.5 million to advance vaccine against S. aureus
CARB-X funds LimmaTech Biologics AG to develop a vaccine that prevents ...
Management | LimmaTech Biologics AG
Valneva, LimmaTech Begin Phase 2 Infant Trial for Shigella Vaccine
LimmaTech startet Studie gegen S. aureus-Infektionen
ᐈ LimmaTech Biologics Secures Exclusive Rights for Breakthrough Vaccine ...
What is Sales and Marketing Strategy of LimmaTech Biologics Company ...
LimmaTech Biologics: 37 Mio. US-Dollar in Serie A
LimmaTech in exclusive license agreement with Griffith University to ...
Franz-Werner Haas wird neuer CEO von Limmatech – ChemieXtra – Die ...
Leadership | LimmaTech Biologics AG
Chinaza E. - Senior Clinical Project Manager at LimmaTech Biologics AG ...
A Brief History of LimmaTech Biologics – CanvasBusinessModel.com
LimmaTech Biologics AG | Home
LimmaTech Biologics Raises $37 Million Series A to Advance Its ...
Limbach Holdings logo in transparent PNG and vectorized SVG formats
LimmaTech Biologics AG on LinkedIn: #waaw #vaccines # ...
LimmaTech will be presenting at 23. BIO€QUITY Europe 2023 in Dublin
CARB-X on LinkedIn: CARB-X is awarding US$2.2M to LimmaTech Biologics ...
What is Customer Demographics and Target Market of LimmaTech Biologics ...
LimmaTech Biologics AG on LinkedIn: #amr #vaccines #globalhealth # ...
Swiss-based LimmaTech Biologics raises €35M to combat emerging ...
Valneva pays LimmaTech $10M for Shigella vaccine
Careers | LimmaTech Biologics AG
LimmaTech Biologics AG on LinkedIn: #icymi #vaccines # ...
LimmaTech Biologics AG | LinkedIn
LimmaTech Awarded FDA Fast Track Designation for Vaccine Candidate ...
LimmaTech STI Research Awarded $2.2 Million Dollars by CARB-X - The ...
Valneva and LimmaTech Awarded FDA Fast Track Designation for ...
Valneva and LimmaTech Initiate Phase 2 Study for Shigella Vaccine ...
LSX World Congress 2020 Presentations - Limmatech Biologics - YouTube
LimmaTech Biologics Secures $3M in Initial Phase of Funding ...
COMDAT DATASYSTEMS AG
LifeMark-100 Product Page | LimnTech
#vaccine #antimicrobialresistance #amr #infection #clinicaltrial # ...
Swiss vaccine developer Limma Tech get CARB-X grant - European ...
Limbach to Announce Second Quarter 2025 Results
File:Limbach Gruppe Logo.svg - Wikimedia Commons
Pharmaceutical Technology
Clinical Development of a Vaccine - ECCRT
FCF Fox Corporate Finance GmbH on LinkedIn: #bacterialvaccines # ...
LammTech - Crunchbase Company Profile & Funding
速递 | 推进耐药性细菌感染疫苗开发，这家公司完成3700万美元融资_腾讯新闻
